Navigation Links
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
Date:12/7/2007

ATLANTA, Dec. 7 /PRNewswire/ -- Ortho Biotech today announced that 12 clinical studies of DOXIL(R) (doxorubicin HCl pegylated liposome injection) will be presented at the 49th annual meeting of the American Society of Hematology (ASH) at the Georgia World Congress Center on December 8-11, 2007.

"We are very pleased that ASH accepted these 12 studies for presentation," said Craig Tendler, M.D., Vice President, Medical Affairs, Oncology/Nephrology, Ortho Biotech Products, L.P. "These presentations are further evidence of Ortho Biotech's ongoing commitment to developing oncology therapeutics and to helping patients with cancer."
The 12 presentations include:

-- Phase I/II Study of Rituxan in Combination with DOXIL in Patients with

Relapsing or Refractory B-Cell Lymphoma: Clinical Efficacy without

Cardiac Toxicity - Myron S. Czuczman, Roswell Park Cancer Institute,

Buffalo, NY (Abstract 1369)

-- Saturday, December 8, 2007, 5:30 p.m.-7:30 p.m., Hall B3 and B4

(Poster Board #: 523-I)

-- Gene Expression Profiles (GEP) to Predict at Least Very Good Partial

Response to VELCADE, DOXIL, and Dexamethasone in Newly Diagnosed

Patients with Multiple Myeloma - Malathi Hari, University of Michigan,

Ann Arbor (Abstract 1489)

-- Sunday, December 9, 2007, 5:30 p.m.-7:30 p.m., Hall B3 and B4

(Poster Board #:643-I)

-- Pegylated Liposomal Doxorubicin in Combination with Bortezomib May

Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients

Relapsing within 12 Months of Stem Cell Transplant - Shaji Kumar, Mayo

Clinic, Rochester, MN (Abstract 2730)

-- Sunday, December 9, 2007, 6:00 p.m.-8:00 p.m., Hall B3 and B4

(Poster Board #:920-II)

-- Effect of Disease Stage and Time Since Diagnosis on Time to Progression

for Pegylated Liposomal Doxorubicin + Bortezomib vs. Bortezomib Al
'/>"/>

SOURCE Ortho Biotech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... According to the new ... (Electric, Battery, Pneumatic), by Product (Drill, Saw, Stapler, ... Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global ... Surgical Instruments Market is estimated to be worth ... is expected to grow at a moderate CAGR ...
(Date:11/26/2014)... , Nov. 25, 2014 ... focused on the development of mobile diagnostic ... testing in hospital and pre-hospital settings, today ... (ISO) 13485:2003 certification.  The certification was awarded ... of the world,s leading certification bodies. ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2
... Silence Therapeutics plc (AIM: SLN) ("Silence" or ... patent 7,893,245, titled "Interfering RNA Molecules," by the ... issued patent, which represents a continuation of previously ... RNAi molecules with defined positional modifications including siRNA ...
... Feb. 22, 2011 Covance Inc. (NYSE: CVD ... Annual Morningstar/NYSSA Healthcare Conference on Thursday, February 24, 2011 at ... the presentation at www.covance.com .  In order to register ... early. Covance, with headquarters in Princeton, New Jersey, ...
Cached Medicine Technology:Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials 2Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials 3Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials 4Covance to Present at the 2nd Annual Morningstar/NYSSA Healthcare Conference 2
(Date:11/27/2014)... 2014 “Wekho” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers ... , An interesting new way to travel and experience the ... It’s called Wekho and it’s a free geolocation app ...
(Date:11/27/2014)... November 27, 2014 Dr. Ronald Receveur, who ... has a few oral health tips before patients dig into ... Louisville and New Albany affordable cosmetic dentistry, and ... in starch and sugar. While the staff wishes everyone a ... tips for how patients can enjoy a feast that is ...
(Date:11/27/2014)... Aria Health President and CEO Kathleen ... donated 200 Thanksgiving dinners on Friday, November 21, ... non-profit, community-based organization committed to serving vulnerable children, ... were assembled in the dining hall of the ... vulnerable low income seniors in the Philadelphia community. ...
(Date:11/27/2014)... Marietta, GA (PRWEB) November 27, 2014 "The ... the whole month of December is full of laughter as ... Tandy Wilson won by making a sweater from scratch. " ... lit Christmas tree, and if that weren't ridiculous enough, the ... on top. , For those interested in participating this ...
(Date:11/27/2014)... Santa Rosa, California (PRWEB) November 27, 2014 ... – Bringing You An Up-Close Look At This Year’s ... Prize Of An All-Inclusive Stay For Two At Their ... York-based High Times events or L.A.-based Hempcon, The Emerald ... state’s definitive county fair draws much of California’s original ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4
... difficult economic times, when people,s stress levels - both ... essential than ever, according to the experts at the ... many are today, we need all the help we ... and ADA Spokesperson Amy Jamieson-Petonic. "While eating healthfully is ...
... an affiliate member of ACA International – the Association of Credit ... , ... (Vocus) March 10, 2009 -- Prosodie Interactive, ... 33324-3223, was accepted as an affiliate member of ACA International – ...
... solutions for managing scientific R&D knowledge, information and processes, proudly ... Board of Directors. , ... Cork, ... LTD ("KineMatik"), providers of software solutions for managing scientific ...
... Amilpar ( BOVESPA: AMIL3, Bloomberg: AMIL3 BZ e Reuters: ... today its consolidated results for the periods ended on December ... at 3.2 million at the end of December, 18.4% up ... the previous quarter. , Adjusted Operating Revenues totaled ...
... 11 , New research released to ... (36%) of the nine million smokers in Great Britain are thinking,about ... of the economic,downturn. The poll also shows that one in ten ... on No Smoking Day. , No Smoking ...
... after treatment stops -SAN FRANCISCO, March 10 ... formulation of liquor carbonis distillate (LCD), known as ... cream in improving and controlling the symptoms of ... the American Academy of Dermatology,s 2009 Annual Meeting. ...
Cached Medicine News:Health News:A Registered Dietitian Can Help You Weather Economic Troubles Through Nutrition and Health, Says American Dietetic Association 2Health News:Business Becomes Affiliate Member of International Trade Association 2Health News:Mr. Ruben Jose King-Shaw Jr. to Join KineMatik Board of Directors 2Health News:Mr. Ruben Jose King-Shaw Jr. to Join KineMatik Board of Directors 3Health News:Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 3Health News:Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis 2Health News:Study Shows Nonprescription LCD Topical Solution is More Effective than Prescription-Strength Calcipotriol Cream for Moderate Plaque Psoriasis 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: